Select for export MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211058923 PubMed 34983249 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-04 Jones GM, Nock MK. Europe PMC Published psilocybin Observational StudyAdolescentsSafety Observational Study More
Select for export Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211066714 PubMed 34983261 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-04 Jones GM, Nock MK. Europe PMC Published psilocybin DepressionAddictionChronic Pain Observational Study More
Select for export Differential effects of repeated treatment with DOI and psilocybin on the head-twitch response (HTR), locomotor activity and anxiety-like behaviour No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100764 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 E. Stojek, Jack Prenderville, F. Dunphy-Doherty OpenAlex Published psilocybin Anxiety Other More
Select for export Effects of psilocybin in relative and global cerebral blood flow and behavioural correlates No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100702 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 Nathalie M. Rieser, Ladina P Gubser, Franz X. Vollenweider, Meyer Lars, Katrin H. Preller OpenAlex Published psilocybin General Other More
Select for export Acute change in functional brain entropy following psilocybin administration in healthy volunteers No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100701 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 Drummond E-Wen McCulloch, Anders Smærup Olsen, Dea Siggaard Stenbæk, Sophia Armand, M.K. Madsen, Gitte M. Knudsen OpenAlex Published psilocybin PharmacologyHealthy Volunteers Other More
Select for export SPECIAL ISSUE: Do Biofeedback, Neurofeedback, and Neuromeditation Have a Role in Psychedelic-Assisted Therapies? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.5298/1081-5937-50.03.03 Copy citation Copy BibTeX Biofeedback 2021-12-31 Jeff Tarrant OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Psilocybin may be effective for treatment-resistant depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1211/pj.2022.1.164911 Copy citation Copy BibTeX Pharmaceutical journal/The pharmaceutical journal 2021-12-31 Authors unavailable OpenAlex Published psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export Investigating cue-reactivity as biomarker for treatment success in psilocybin-assisted therapy for alcohol use disorder No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100102 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 Nathalie M. Rieser, Ladina P Gubser, C. Rossgoderer Da Silva, Franz X. Vollenweider, Marcus Herdener, Katrin H. Preller OpenAlex Published psilocybin AddictionBiomarkers Other More
Select for export The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100213 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 G. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, D. Feifel, David J. Hellerstein, L. Marwood OpenAlex Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100511 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt OpenAlex Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Pharmacokinetics and pharmacokinetic-pharmacodynamic relationship of oral psilocybin administration in healthy subjects No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100410 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 Friederike Holze, A. Becker, Karolina E. Kolaczynska, Urs Duthaler, Matthias E. Liechti OpenAlex Published psilocybin Pharmacology Other More
Select for export Should Adolescents be Included in Emerging Psychedelic Research? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7202/1089784ar Copy citation Copy BibTeX Canadian Journal of Bioethics 2021-12-31 Khaleel Rajwani OpenAlex Published psilocybin AdolescentsSafety Other More
Select for export Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2021_267 PubMed 34734390 Copy citation Copy BibTeX Current topics in behavioral neurosciences 2021-12-31 Garcia-Romeu A, Darcy S, Jackson H, White T, Rosenberg P PubMed Published psilocybin AnxietyNeuroplasticityMechanism of Action Review Article More
Select for export Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1107/s2053229621013164 PubMed 34982048 Copy citation Copy BibTeX Acta Crystallographica Section C Structural Chemistry 2021-12-31 Sherwood AM, Kargbo RB, Kaylo KW, Cozzi NV, Meisenheimer P, Kaduk JA. Europe PMC Published psilocybin Clinical Trial Clinical Trial More
Select for export Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.831092 PubMed 35370864 Copy citation Copy BibTeX Frontiers in psychiatry 2021-12-31 Raison CL, Jain R, Penn AD, Cole SP, Jain S PubMed Published psilocybin DepressionAnxietyWellbeing Clinical Trial More
Select for export Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2021.1971343 PubMed 34468293 Copy citation Copy BibTeX Journal of psychoactive drugs 2021-12-31 Davis AK, Agin-Liebes G, España M, Pilecki B, Luoma J PubMed Published psilocybin Observational StudySafety Observational Study More
Select for export The economics of psychedelic-assisted therapies: A research agenda. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.1025726 PubMed 36545038 Copy citation Copy BibTeX Frontiers in psychiatry 2021-12-31 Marseille E, Bertozzi S, Kahn JG PubMed Published psilocybin DepressionPTSDAddiction Other More
Select for export Critique of the Royal Australian and New Zealand College of Psychiatrists Psychedelic Therapy Clinical Memorandum, Dated May 2020 Abstract available at the source but not redistributed here. Read at source. Details DOI 10.32996/jmhs.2021.2.2.18 Copy citation Copy BibTeX Journal of Medical and Health Studies 2021-12-30 Victor Chiruta, Paulina K Zemla, Pixie Miller, Nicola Santarossa, John A Hannan OpenAlex Published psilocybin SafetyToxicity Other More
Select for export Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s12904-021-00889-x PubMed 34930220 Copy citation Copy BibTeX BMC palliative care 2021-12-19 Niles H, Fogg C, Kelmendi B, Lazenby M PubMed Published psilocybin End-of-Life DistressSpiritualityClinical Trial Clinical Trial More
Select for export Double-blind Placebo-controlled Naturalistic Study of Microdosing With Psilocybin: Effects on Brain Activity, Behavior, Cognition, Creativity, and Mental Health Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2021-12-15 National Council of Scientific and Technical Research, Argentina ClinicalTrials.gov CLINICAL TRIAL psilocybin Brain ImagingMechanism of ActionMicrodosing Other More
